Myriad Genetics posted Q2 revenue growth of 1% year-over-year, but adjusted for one-time events, growth would have been 5%.

Adeno-associated virus (AAV) is a widely used gene therapy vector for treating hereditary retinal diseases, which are caused by mutations in genes cr ...

Discover the facts about CLOVES syndrome—an extremely rare genetic disorder with complex symptoms and challenging diagnosis.

Discover the competitive landscape of AAV gene therapy for hereditary retinal diseases, featuring insights on 75+ companies and 80+ drugs. This comprehensive report highlights key advancements, ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

Baby with 1 Dad, 2 Mums brings major breakthrough in hereditary disease prevention and infertility treatment, doctors shed ...

An international research team has identified a new protein that specifically transports enzymes into peroxisomes. Its mode ...

Recent advancements in genomic technologies have greatly advanced our understanding of genomic regions implicated in disease processes, including ...

Th<span id="cke_bm_479S" style="display:no is study aimed to bridge that gap by conducting genetic analysis on a cohort of ...

Children born through the three-person technique inherit most of their DNA, their genetic blueprint, from their parents, but ...

A new fertility method in the UK allows babies to be born with DNA from three people. This technique helps prevent inherited diseases. At least eight ...

Chiesi Global Rare Diseases (Chiesi) proudly shares its contribution to the thought-provoking film 'Living Between Pain and ...